THRB Genetic Polymorphisms Can Predict Severe Myelotoxicity after Definitive Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

Objective: Chemotherapy-related toxicities are difficult to predict before treatment. In this study, we investigated whether thyroid hormone receptor beta (THRB) genetic polymorphisms can serve as a potential biomarker in patients with esophageal squamous cell carcinoma (ESCC). Methods: Forty-nine J...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Miki, Ikuya, Nakamura, Tsutomu, Kuwahara, Akiko, Yamamori, Motohiro, Nishiguchi, Kohshi, Tamura, Takao, Okuno, Tatsuya, Omatsu, Hideaki, Mizuno, Shigeto, Hirai, Midori, Azuma, Takeshi, Sakaeda, Toshiyuki
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2012
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491433/
https://ncbi.nlm.nih.gov/pubmed/23136537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.5081
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items